"On November 2, 2016, OWC Pharmaceutical Research Corp. accepted the resignation of Dr. Asaf Toker as Chief Science Officer, a position to which he was appointed in October 2015. In Dr. Toker's letter of resignation, a copy of which is attached as Exhibit 17.4 hereto, Dr. Toker stated that the reason for my resignation is to permit me to pursue other business interests. I have had no disagreements with the Registrant's operations, policies or practices. Effective on November 2, 2016, and in connection with the acceptance of Dr. Toker's resignation, the Registrant immediately appointed Dr. Yehuda Baruch, as Chief Science Officer. "

https://www.sec.gov/Archives/edgar/data/14319...000733.txt